updated
5:30 p.m. ET April 25, 2008<SCRIPT language=javascript> function UpdateTimeStamp(pdt) { var n = document.getElementById("udtD"); if(pdt != '' && n && window.DateTime) { var dt = new DateTime(); pdt = dt.T2D(pdt); if(dt.GetTZ(pdt)) {n.innerHTML = dt.D2S(pdt,((''.toLowerCase()=='false')?false:true ));} } } UpdateTimeStamp('633447558452200000');</SCRIPT>
CHICAGO - Two of the largest and longest studies so far show a “brain pacemaker” can effectively treat depression and obsessive-compulsive disorder, researchers said on Friday.
Devices implanted in the chest, with leads that send electrical impulses to parts of the brain, have already been approved to treat movement disorders, such as Parkinson’s disease, essential tremor and dystonia.
Dr. Ali Rezai, head of neurosurgery at the Cleveland Clinic, who led the studies, said the technique known as deep brain stimulation helped the most severely depressed patients improve significantly.
Researchers from Butler Hospital/Brown Medical School, Massachusetts General Hospital and Harvard Medical School were also involved in the depression study.
Seventeen paarea of the brain and is likely to generate similar findings.
He said there were no serious side effects in using the Medtronic device.
The trial treating OCD included 26 patients who were followed for three years and also showed marked improvement.
Butler Hospital/Brown University, University of Florida and University of Leuven also contributed to the OCD study.
Medtronic has an application before the U.S. Food and Drug Administration for approval to use deep brain stimulation for OCD.
A clinical trial using the treatment for severe depression will be initiated this year.
The FDA in 2005 approved Cyberonics Inc implantable device for treatment-resistant depression. It sends signals to the brain via the vagus nerve in the neck.
Source :
http://www.msnbc.msn.com/id/24317065/